ATE31116T1 - Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen. - Google Patents

Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen.

Info

Publication number
ATE31116T1
ATE31116T1 AT84105690T AT84105690T ATE31116T1 AT E31116 T1 ATE31116 T1 AT E31116T1 AT 84105690 T AT84105690 T AT 84105690T AT 84105690 T AT84105690 T AT 84105690T AT E31116 T1 ATE31116 T1 AT E31116T1
Authority
AT
Austria
Prior art keywords
carriers
virus
pseudorabies
swine
pseudorabiesviral
Prior art date
Application number
AT84105690T
Other languages
English (en)
Inventor
Kenneth B Platt
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Application granted granted Critical
Publication of ATE31116T1 publication Critical patent/ATE31116T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT84105690T 1983-05-31 1984-05-18 Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen. ATE31116T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49920483A 1983-05-31 1983-05-31
EP19840105690 EP0133200B1 (de) 1983-05-31 1984-05-18 Diagnostisches Antigen für Träger der durch Pseudorabiesviren verursachten Krankheit bei Schweinen

Publications (1)

Publication Number Publication Date
ATE31116T1 true ATE31116T1 (de) 1987-12-15

Family

ID=23984274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84105690T ATE31116T1 (de) 1983-05-31 1984-05-18 Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen.

Country Status (4)

Country Link
EP (1) EP0133200B1 (de)
AT (1) ATE31116T1 (de)
CA (1) CA1241596A (de)
DE (1) DE3467813D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804624A (en) * 1982-05-21 1989-02-14 The University Of Tennessee Research Corporation Passive agglutination assay for pseudorabies antibody
US4820629A (en) * 1983-05-31 1989-04-11 Iowa State University Research Foundation, Inc. Immunoassay for antibodies to pseudorabies virus using medium-elaborated viral antigenic factor
US5041370A (en) * 1984-05-02 1991-08-20 The Upjohn Company Pseudorabies virus (PRV) gene, host cell, method for detecting animals infected with pseudorabies virus, and kit therefor
US5041536A (en) * 1984-05-02 1991-08-20 The Upjohn Company Pseudorabies virus (PRV) gene
US5128128A (en) * 1985-07-29 1992-07-07 The Upjohn Company Virus vaccine
US5275934A (en) * 1985-07-29 1994-01-04 The Upjohn Company Method of detecting viral infection in vaccinated animals
US5352575A (en) * 1985-10-04 1994-10-04 The Upjohn Company Pseudorabies virus protein
US6172186B1 (en) 1986-03-26 2001-01-09 Pharmacia & Upjohn Company Pseudorabies virus protein
US5122447A (en) * 1989-01-23 1992-06-16 Iowa State University Research Foundation, Inc. Method of detecting pseudorabies virus specific serum antibody by use of a universal diagnostic antigen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8102786A (nl) * 1981-06-10 1983-01-03 Duphar Int Res Werkwijze voor het immuniseren van varkens tegen de ziekte van aujeszky.
ZA84467B (en) * 1983-02-01 1984-09-26 Upjohn Co Pseudorabies vaccine

Also Published As

Publication number Publication date
DE3467813D1 (en) 1988-01-07
EP0133200B1 (de) 1987-11-25
EP0133200A1 (de) 1985-02-20
CA1241596A (en) 1988-09-06

Similar Documents

Publication Publication Date Title
DE68924162D1 (de) Stressproteine und verwendungen dafür.
ATE17320T1 (de) Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben.
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
NZ230148A (en) Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd
DK388384A (da) Monoklone antistoffer med specifitet for membran-associerede antigener, deres fremstilling og anvendelse
ATE31116T1 (de) Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen.
DK0465204T3 (da) Vaccine mod Lyme sygdom
FI864991A (fi) Expression och diagnostisk anvaendning av peptider kodade av gag-region vilka peptider aer immunologiskt reaktiva med antikroppar av lav-virus.
FI924457A (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
DK218886D0 (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
ATE273022T1 (de) Verfahren zur verstärkung zellularer immunantworten
ZA873922B (en) Method of preparation and use for feline leukemia virus antigens
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
SE8201128L (sv) Forfarande for reproduktion av virulent treponema pallidum i vevnadsk ultur
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
FI972658A (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
SU1197642A1 (ru) Способ определени состо ни сенсибилизации организма к вирусу гриппа
Wicher et al. Lymphocyte transformation in inbred guinea pigs infected with Treponema pallidum Nichols
DE59209899D1 (de) Rekombinante Proteine mit der Immunreaktivität des Hepatitis B Virus e Antigens (HBeAg), Verfahren zu ihrer Herstellung und ihre Verwendung in Immunoassays und Impfstoffen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee